Report Overview
China Charcot-Marie-Tooth disease (CMT) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Charcot-Marie-Tooth (CMT) disease is a group of disorders in which the motor and/or sensory peripheral nerves are affected, resulting in muscle weakness and atrophy, as well as sensory loss. These manifestations occur first in the distal legs and later in the hands. In China the overall incidence of CMT is about 40/100,000.
Market Drivers
China is a growing market for Charcot-Marie-Tooth disease (CMT) due to factors such as increase in Chinas incidence rate (40/100,000). In addition to this, other factors that contribute to the growth of the market are increase in genetic disorders and increased focus towards targeted therapies.
However, there are some restraining factors for growth of Charcot-Marie-Tooth disease (CMT) therapeutics market in China such high cost of treatment.
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.